Urology robotic surgery market is anticipated to grow at a considerable CAGR of 11.5% during the forecast period. The growth of the market is attributed to factors such as technological advancements in robotic surgery systems, increasing prevalence of urological disorders, and rising adoption of robotic surgery by healthcare providers. As a result of all these factors, the market players are focusing on adopting new strategies such as partnerships and other to stay competitive in the market by offering updated medical facilities. For instance, in January 2019, Accuray Incorporated and The Urology Group (TUG) partnered to provide prostate cancer patient support. With this partnership TUG physicians treated the center’s 1,600th prostate cancer patient using the CyberKnife® M6™ System, a radiotherapy device that specializes in delivering stereotactic body radiation therapy (SBRT) treatments with sub-millimeter precision. The system’s unique design and advanced treatment planning software help enable physicians to avoid healthy tissue and minimize side effects on urinary, bowel, and sexual function that can reduce a man’s quality of life.
Get Free Sample link @ https://www.omrglobal.com/request-sample/urology-robotic-surgery-market
This means that the surgery can be performed through small incisions, which results in less pain, scarring, and a faster recovery time for the patient. It has also allowed for greater surgical precision, which has reduced the risk of complications and improved outcomes for patients. The growing advancement in robotic procedures and launches of innovative robots by key players is driving market growth. For instance, in May 2022, Johnson & Johnson received FDA clearance for its Monarch robotic surgery system, allowing the robot to be used in kidney stone removal procedures. This latest FDA 510(k) clearance for Monarch delivers the company’s vision to extend the robotic platform’s capabilities across multiple specialties, enabling hospital systems to target two disease states using one device. With the new urological clearance, doctors will be able to use the surgical robot to snake an endoscope into the kidney to break up and suction out kidney stones, with an attached camera providing a real-time view of the area the whole time.
full report of Urology Robotic Surgery Market available @ https://www.omrglobal.com/industry-reports/urology-robotic-surgery-market
- Market Coverage
- Market number available for – 2023-2029
- Base year- 2022
- Forecast period- 2023-2029
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Global Urology Robotic Surgery Market Report Segment
By Component
- Robotic Surgery Systems
- Instruments
- Accessories
- Services
By Type
- Robot Machines
- Navigation Systems
- Planners
- Simulators
- Others
By Application
- Robotic Prostatectomy
- Robotic Cystectomy
- Robotic Pyeloplasty
- Robotic Nephrectomy
- Others
Global Urology Robotic Surgery Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/urology-robotic-surgery-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
